Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
Introduction of drug-eluting stents for percutaneous coronary interventions opened novel options for treating coronary heart disease (CHD) in patients with diabetes mellitus. However, mortality and myocardial infarction rates are still higher among diabetes patients. They also require repeated revas...
Guardado en:
Autores principales: | Marina Sergeevna Michurova, Irina Vladimirovna Kononenko, Olga Mikhailovna Smirnova, Victor Yur'evich Kalashnikov |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e58e32fb4e6c43c8a05590da5d4e18bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mobilization of endothelial progenitor cells after endovascular interventions in patients with type 2 diabetes mellitus
por: Marina Sergeevna Michurova, et al.
Publicado: (2014) -
Endothelial progenitor cells and vascular endothelial growth factor after endovascular interventions in patients with type 2 diabetes
por: Marina Sergeevna Michurova, et al.
Publicado: (2017) -
Antihyperglycemic therapy in patients with type 2 diabetes mellitus and ischaemic heart disease: management during acute period of myocardial infarction and interventional procedures
por: Olga Mikhailovna Smirnova, et al.
Publicado: (2012) -
Long-term comparison of everolimus- vs.
novolimus-eluting bioresorbable vascular scaffolds
in real world patients
por: Beytullah Cakal, et al.
Publicado: (2020) -
Myocardial revascularization in patients with type 2 diabetes mellitus: An overview of modern techniques
por: Elena Zelikovna Golukhova, et al.
Publicado: (2016)